Core Scientific Q2 Earnings Preview: AI Pivot vs. Bitcoin Mining Legacy

• Core Scientific is scheduled to release Q2 2026 financial results before the market opens on Friday, August 14, with consensus estimates projecting a loss of $0.02 per share and revenue of approximately $144.9 million.
• The upcoming report follows a significant earnings miss in the prior quarter, where the company posted an EPS of ($3.32) against expectations of ($0.06), although revenue came in higher at $164.20 million.
• Analysts maintain a generally positive outlook, with firms like Canaccord Genuity and Cantor Fitzgerald recently raising price targets to $36.00 and $29.00 respectively, reflecting optimism about the company's strategic positioning.
• Core Scientific is actively executing a transition from traditional Bitcoin mining to Artificial Intelligence and High-Performance Computing (AI/HPC), highlighted by a major multi-gigawatt infrastructure agreement with AMD.

Core Scientific is preparing to report its second-quarter 2026 financial results, a period that has been defined by mixed signals and a clear operational pivot. The company is scheduled to release its earnings before the market opens on Friday, August 14, 2026. Consensus estimates from equity research firms project a modest loss of $0.02 per share and revenue of approximately $144.9 million for the quarter ending June 2026 ().

This forward-looking projection stands in sharp contrast to the previous quarter's performance. On July 28, 2026, Core Scientific reported an EPS of ($3.32), which significantly missed analyst expectations of ($0.06) . Despite this earnings miss, revenue for that period came in at $164.20 million, beating the consensus estimate of $144.83 million . The discrepancy between revenue strength and profitability highlights the transitional costs associated with the company's broader strategic shifts.

Market sentiment remains cautiously optimistic among institutional investors. Canaccord Genuity Group recently raised its price target from $30.00 to $36.00, assigning a "buy" rating to the stock . Similarly, Cantor Fitzgerald boosted its price target from $25.00 to $29.00 with an "overweight" rating . Capital One Financial has also set a $33.00 price objective . These upgrades suggest that analysts view the current volatility as a temporary phase rather than a fundamental deterioration of the business model.

How Is Core Scientific Shifting to AI Infrastructure?

The core narrative driving Core Scientific's valuation is its strategic pivot to AI/HPC. This shift is not merely aspirational but has been formalized through significant contractual agreements. The company secured a multi-gigawatt, 15-year infrastructure agreement with AMD to supply initial U.S. AI data-center capacity starting in 2027 .

The AMD deal is substantial, covering 530 megawatts across five sites and generating over $14 billion in base revenue over the 15-year term, with 2.5% annual escalators. The deployment schedule is aggressive, with the first AMD megawatts expected in the first half of 2027 . The company targets a delivery of 265 megawatts in 2027 and the remaining 265 megawatts in 2028, aiming for a total annual capacity of 600 megawatts by the end of 2028 .

In Q2, the company's colocation revenue reached $137 million, with billable capacity rising to 437 megawatts by mid-July, an increase of nearly 200 megawatts from the first quarter . To facilitate this transition, Core Scientific ended its Block chip purchase program, taking a $41.9 million loss on the transaction . This move further cements the redirection of capital toward AI/HPC operations .

Simultaneously, the company is reducing its traditional mining footprint by 30% from the first quarter while pursuing an additional 2-gigawatt site pipeline . Bitcoin holdings increased to 848 BTC, a rise of 301 BTC from the previous period, but the company continues to scale back mining-specific hardware procurement .

Why Are Investors Skeptical Despite Strong Contracts?

Despite the ambitious AI infrastructure plans, investor sentiment has shown signs of caution. Following the Q1 report, shares rallied approximately 20% due to positive momentum in the AI sector, but recent trading has been volatile . The stock opened at $21.05 with a market capitalization of $6.76 billion, carrying a high beta of 5.59, which indicates significant price sensitivity .

A major concern for investors is the substantial capital expenditure required to realize the AI pipeline. The AMD deal and associated infrastructure build-out require approximately $6 billion in capital . This heavy capex requirement, combined with the extended timeline to fully realize revenue through 2028, has led to a pullback in share price . Shares fell 3.13% to $20.09 following reports of the strong results, as investors weighed the funding gap against the long-term rewards .

Broader industry analysis from VanEck highlights a critical divergence between AI contracts and operational reality across the Bitcoin mining sector. As of mid-2026, only approximately 25% of the leased AI capacity has been brought online industry-wide . This execution lag is compounded by a near-term funding gap estimated at $50 billion, with long-term requirements potentially reaching $221 billion .

Investor valuation metrics are shifting away from hashrate or Bitcoin treasuries toward energized AI capacity and delivery track records . While some operators project AI could account for over 70% of revenues by the end of 2026, the sector remains divided between those with secured long-term contracts and those heavily correlated to Bitcoin's price . Core Scientific's ability to execute on its $6 billion capex plan will be a critical test of this new valuation paradigm.

Looking ahead, analysts expect an average loss of $1 per share for the current fiscal year and breakeven ($0 EPS) for the next . The upcoming Q2 report will be closely watched to see if the company can demonstrate further progress in its AI infrastructure build-out and manage the financial burdens of the transition. The stock's 52-week range of $13.14 to $30.46 reflects the high stakes of this pivot .